Improving Clinical Management and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis in China via Real-world Evidence (IMPROVE Study): A Multicenter Prospective Cohort Study
Patients with RA with MDA/HDA in China experienced significant improvement in pain and fatigue over 6 months. Improvement in DAS28-CRP was associated with faster improvement in certain PROs. While disease activity correlated with some PROs, they did not fully capture patient experience, highlighting the importance of PROs in RA management.
Authors
- Xinwang Duan (ORCID: https://orcid.org/0000-0002-0432-3638)
- Dongzhou Liu
- Xinping Tian (ORCID: https://orcid.org/0000-0002-1511-7952)
- Nan Jiang (ORCID: https://orcid.org/0000-0002-0671-6822)
- Lijun Wu (ORCID: https://orcid.org/0000-0002-3813-822X)
- Xiaofeng Zeng (ORCID: https://orcid.org/0000-0002-3883-2318)
- Yanjie Zhang (ORCID: https://orcid.org/0000-0002-7964-2326)
- Yi Liu (ORCID: https://orcid.org/0000-0003-4030-9670)
- Hao Zhu
- Mengtao Li
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Nanchang University (CN)
- Jinan University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sichuan University (CN)
- Peking Union Medical College Hospital (CN)
- Southern University of Science and Technology (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- West China Hospital of Sichuan University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1007/s12325-025-03179-7
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company